Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: $$$.19 with a bullet

"Ibis has a strong track record of success in introducing companies such as ours to institutional investors driving long term institutional shareholders of Patriot. I am very pleased to partner with Ibis to communicate Patriot's exciting and evolving transition story," said Patriot President and CEO Rick Goerner



I believe this is the type of high level exposure Ronran was hoping Pohl, and Turley would have done for our company two years ago...

Share
New Message
Please login to post a reply